UBXN10 as A Potential Drug Target and Biomarker for Neurological Disorders

Target Name: UBXN10

NCBI ID: G127733

UBXN10

UBXN10 as A Potential Drug Target and Biomarker for Neurological Disorders

UBXN10 (UBX10_HUMAN), a protein expressed in human tissues, has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. Its unique structure and expression pattern across different brain regions suggest a potential role in the development and progression of these conditions.

The UBXN10 protein is a member of the Xenopus complement system, a family of proteins involved in the regulation of cell death and survival. The Xenopus complement system has been implicated in a wide range of physiological processes, including inflammation, stress response, and development.

UBXN10 has been shown to be expressed in various human tissues, including brain, heart, and skeletal muscles. Its expression pattern suggests a role in the development and maintenance of tissues, as well as in the regulation of cellular processes such as cell survival and angiogenesis.

One of the most significant features of UBXN10 is its expression pattern in the brain. UBXN10 is expressed in the cerebral cortical cortical plate, which is the outermost layer of the brain and is responsible for various functions such as motor coordination, attention, and memory.

The expression of UBXN10 in the cerebral cortical cortical plate is also consistent with its known function in the regulation of cellular processes in the brain. Studies have shown that UBXN10 plays a role in the regulation of neurotransmitter release from neurons, which is critical for the function of the brain.

In addition to its expression in the brain, UBXN10 has also been shown to be involved in the regulation of cellular processes in other tissues. For example, studies have shown that UBXN10 is expressed in heart muscle, where it plays a role in the regulation of ion channels and contractions.

The unique expression pattern of UBXN10 across different tissues and brain regions suggests that it may be a promising drug target for a wide range of neurological and psychiatric disorders. Its potential role in the regulation of cellular processes in the brain and other tissues also makes it an attractive biomarker for the diagnosis and treatment of these conditions.

In conclusion, UBXN10 is a protein with significant potential as a drug target and biomarker for a wide range of neurological and psychiatric disorders. Its unique expression pattern across different tissues and brain regions, as well as its known function in the regulation of cellular processes in the brain, make it an attractive target for the development of new treatments for these conditions. Further research is needed to fully understand the role of UBXN10 in the regulation of cellular processes in the brain and its potential as a drug target.

Protein Name: UBX Domain Protein 10

Functions: VCP/p97-binding protein required for ciliogenesis (PubMed:26389662). Acts as a tethering factor that facilitates recruitment of VCP/p97 to the intraflagellar transport complex B (IFT-B) in cilia (PubMed:26389662). UBX domain-containing proteins act as tethering factors for VCP/p97 and may specify substrate specificity of VCP/p97 (PubMed:26389662)

The "UBXN10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBXN10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets